Jani Tuomi of Microdrop's imaware at-home health testing - Top Entrepreneurs Podcast

Jani Tuomi the Co-founder of Microdrop imaware™ at-home health testing joins Enterprise Fit Radio. Tuomi is part of founding team at imaware™, a revolutionary new at-home testing platform for chronic illness including celiac disease and rheumatoid arthritis.

Listen to host Eric Dye & guest Jani Tuomi discuss the following:

Tell us more about Microdrop and imaware. How did the company first come to fruition and what is imaware?
Why do you feel people more than ever now are inclined to take home based tests rather than visiting the doctor?
You recently got validated by a very coveted scientific journal. Tell us why you decided to contact the journal and what this published paper means for the at-home testing community?
What did the data prove?
How did you decide which at-home tests to start with? And was the decision based on feasibility or was it based on clinical priorities?
What are the limits of at-home testing? Do you envision a world where eventually we can do hundreds of tests routinely just as a matter of staying on top of one’s health or is there a limit to what types of test make sense to do at home?
How much has the Theranos controversy hurt imaware, if at all? Do you encounter significant skepticism from investors or the public?
You currently test for rheumatoid arthritis and for celiac disease. Are you releasing any additional tests this year?
Whom are the faces behind Microdrop besides yourself and who is supporting the imaware initiative?
What is some advice you can provide for others who are just starting a company. Is there anything you wish you had known or would have done differently when just starting?

Jani Tuomi, is the Co-founder of Microdrop imaware™ at-home health testing. Jani Tuomi is part of founding team at imaware™, a revolutionary new at-home testing platform for chronic illness including celiac disease and rheumatoid arthritis.

The imaware™ mission is to help reduce the number of individuals with undiagnosed illness through at-home testing. We utilize home-based small-volume blood collection, and microarray lab-testing equipment with high sensitivity and specificity, to give consumers actionable reports and insights. Once aware of their conditions, patients can engage their doctors who can diagnose symptoms.